Trial intelligence / Profile preview

Local dexmedetomidine for postoperative pain after perianal surgery

IRCT20100920004780N11Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of dexmedetomidine in anal fissure and hemorrhoid (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Pain intensity, Nausea and 3 more. Started Aug 2020; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

anal fissurehemorrhoid

Beyond the preview

Go deeper on IRCT20100920004780N11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20100920004780N11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call